Valiant Laborato

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0JWS01017
NSEID: VALIANTLAB
BSEID: 543998
View on NSE | View on BSE

INR

79.56

2.44 (3.16%)

BSENSE

May 06

BSE+NSE Vol: 14.58 k

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.56",
    "chg": 2.44,
    "chgp": "3.16%",
    "dir": 1,
    "prev_price": "77.12",
    "mcapval": "434.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0JWS01017",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "14.58 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3975755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_mojoScore_3975755.png",
        "date": "2026-05-05 10:10:34",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3969816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_stocks_hitting_lower_circuit_3969816.png",
        "date": "2026-04-30 10:00:20",
        "description": "At Rs 77.57, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 30 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3960632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3960632.png",
        "date": "2026-04-24 10:10:31",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3944603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3944603.png",
        "date": "2026-04-13 10:10:32",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3930146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ValiantLaborato_mojoScore_3930146.png",
        "date": "2026-04-02 10:10:29",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3905838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_mojoScore_3905838.png",
        "date": "2026-03-22 10:10:24",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3884930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_mojoScore_3884930.png",
        "date": "2026-03-11 10:10:17",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Falls 5.14% Amid New Lows and Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-514-amid-new-lows-and-weak-financials-3878043",
        "imagepath": "",
        "date": "2026-03-07 11:01:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> New 52-week low at Rs.55</p>\n                    <p><strong>4 Mar:</strong> Stock hits all-time low of Rs.50 amid heavy losses</p>\n                    <p><strong>4 Mar:</strong> Sharp intraday volatility and sector underperformance</p>\n                    <p><strong>6 Mar:</strong> Week closes at Rs.54.04, down 0.95% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.56.97</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.54.04</div><div class=\"stat-change neg..."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs50-3869843",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_priceRelatedfactors_3869843.png",
        "date": "2026-03-04 12:28:53",
        "description": "Valiant Laboratories Ltd’s shares plunged to a fresh 52-week low of Rs.50 on 4 March 2026, marking a significant decline amid persistent underperformance and weak financial metrics. The stock’s fall reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s valuation and profitability indicators signalling challenges in the near term."
      }
    ],
    "total": 304,
    "sid": "10039033",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "23-Apr-2026",
      "details": "Resignation of Mr. Bhanudas D. Patil as the Senior Management Personnel w.e.f April 22 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Apr-2026",
      "details": "For quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Closure of Trading Window for declaration of Financial Results for the quater and year ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Ltd is Rated Strong Sell

2026-05-05 10:10:34

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-04-30 10:00:20

At Rs 77.57, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 30 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-24 10:10:31

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-13 10:10:32

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-04-02 10:10:29

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-03-22 10:10:24

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-03-11 10:10:17

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Valiant Laboratories Ltd Falls 5.14% Amid New Lows and Weak Financials

2026-03-07 11:01:57

Key Events This Week

2 Mar: New 52-week low at Rs.55

4 Mar: Stock hits all-time low of Rs.50 amid heavy losses

4 Mar: Sharp intraday volatility and sector underperformance

6 Mar: Week closes at Rs.54.04, down 0.95% on the day

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50

2026-03-04 12:28:53

Valiant Laboratories Ltd’s shares plunged to a fresh 52-week low of Rs.50 on 4 March 2026, marking a significant decline amid persistent underperformance and weak financial metrics. The stock’s fall reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s valuation and profitability indicators signalling challenges in the near term.